Correlation Between Molecular Partners and Erytech Pharma

Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Erytech Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Erytech Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Molecular Partners AG and Erytech Pharma SA, you can compare the effects of market volatilities on Molecular Partners and Erytech Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Erytech Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Erytech Pharma.

Diversification Opportunities for Molecular Partners and Erytech Pharma

0.0

Correlation Coefficient

Molecular Partners  Erytech Pharma

Pay attention - limited upside

The 3 months correlation between Molecular and Erytech is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Erytech Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erytech Pharma SA and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Erytech Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erytech Pharma SA has no effect on the direction of Molecular Partners i.e., Molecular Partners and Erytech Pharma go up and down completely randomly.

Pair Corralation between Molecular Partners and Erytech Pharma

If you would invest (100.00) in Erytech Pharma SA on November 29, 2024 and sell it today you would earn a total of  100.00  from holding Erytech Pharma SA or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Molecular Partners AG  vs.  Erytech Pharma SA

Molecular Partners

Risk-Adjusted Performance

Very Weak

Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Erytech Pharma SA

Risk-Adjusted Performance

Very Weak

Over the last 90 days Erytech Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Erytech Pharma is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Molecular Partners and Erytech Pharma

The main advantage of trading using opposite Molecular Partners and Erytech Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Erytech Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erytech Pharma will offset losses from the drop in Erytech Pharma's long position.

The idea behind Molecular Partners AG and Erytech Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.